Surgify develops the Surgify Halo™, a precise bone cutting technology designed to minimize complications such as bleeding, infections, and nerve injuries during surgical procedures. This solution enhances surgical safety and accuracy, addressing critical challenges in orthopedic and reconstructive surgeries.
Funding
$5.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional bone cutting methods in surgery can lead to complications such as excessive bleeding, infections, and nerve damage, impacting patient recovery and surgical outcomes. The precision required in orthopedic and reconstructive surgeries is often difficult to achieve with conventional tools.
Solution
Surgify has developed the Surgify Halo™, a bone cutting technology designed to enhance surgical precision and minimize the risk of complications. This technology aims to improve surgical safety and effectiveness by providing surgeons with a more controlled and accurate method for bone removal. The Surgify Halo™ addresses the challenges associated with traditional bone cutting techniques, offering a solution that reduces the potential for adverse events during and after surgery. By focusing on precision and control, Surgify aims to optimize patient outcomes and streamline surgical procedures.
Target Audience
The primary target audience includes orthopedic surgeons and reconstructive surgeons seeking to improve the precision and safety of bone cutting procedures.
Features
- Precise bone cutting technology designed to minimize complications.
- Enhanced surgical safety and accuracy.
- Addresses critical challenges in orthopedic and reconstructive surgeries.